Sign in

Roychoudhuri Lab

@roychoudhurilab.bsky.social
1.5K followers 1.2K following 61 posts

Professor of Cancer Immunology and Immunotherapy University of Cambridge, UK www.roychoudhurilab.org

PostsRepliesMedia
Reposted by Roychoudhuri Lab
Roychoudhuri Lab @roychoudhurilab.bsky.social · 16/08/2026
It's now been 5 years since we replaced our relatively new gas boiler for a #heatpump in our home - and we haven't looked back! Comfortably warm in winter, no damp on walls anymore, ~reduced cost, massive reduction in CO2 emissions. 2-day install! Notes here: sites.google.com/view/becomin...
sites.google.com
Home
We are a family of four living in a 1930's semi-detached house in Cambridge, UK. Here are the steps we've taken to reduce our ecological footprint.
031
Reposted by Roychoudhuri Lab
Roychoudhuri Lab @roychoudhurilab.bsky.social · 04/09/2026
Delighted to share new work published in @science.org entitled 'Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species,' led by @xanwesolowski.bsky.social in the lab science.org/eprint/YQNFA...
33310
Roychoudhuri Lab @roychoudhurilab.bsky.social · 16/09/2026
The convergence on PRDX1 from this and our study using completely different methodologies is remarkable! www.science.org/doi/10.1126/...
science.org
Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species
Reactive oxygen species (ROS) promote genomic instability and fuel oncogenic signaling in cancer, but antioxidant therapies have so far failed to improve, or worsen, cancer outcomes. Emerging data sug...
041
Roychoudhuri Lab @roychoudhurilab.bsky.social · 16/09/2026
Remarkable findings on antioxidant suppression from Julian Lum: CRISPR screen of factors sensitising T cells to the suppressive activity of human ovarian cancer ascites fluid identifies PRDX1 whose deletion increases intracellular ROS and enhances T cell function! www.biorxiv.org/content/10.6...
biorxiv.org
PRDX1 regulates T cell effector function in the ovarian tumor microenvironment
T cell-based immunotherapies have remained ineffective against high-grade serous ovarian carcinoma (HGSOC). The metabolic environment of HGSOC suppresses the activity of cellular therapies, however, t...
020
Reposted by Roychoudhuri Lab
Waggoner Lab @labwaggoner.bsky.social · 08/09/2026
Review @sigtrans-sttt.bsky.social Myeloid-derived suppressor cells in cancer: biology, regulatory networks and theranostic prospects www.nature.com/articles/s41...
001
Reposted by Roychoudhuri Lab
The Lister Institute of Preventive Medicine @thelisterinstitute.bsky.social · 08/09/2026
Long thread on new paper in @science.org. Take a moment to click and read the full explainer! How might these insights shape your own research? Share a comment ♻️
022
Reposted by Roychoudhuri Lab
Rod Rahimi @rodrahimi.bsky.social · 04/09/2026
“The academic clinicians I interviewed wanted to help identify and pursue the most advanced treatments for their patients — it is, after all, what they understand their duty to be — but felt their hands were tied by the red tape of bureaucracy.”🧪🩺
nytimes.com
Opinion | The Search for New Cures Is Broken (Gift Article)
It is too hard for medical researchers to launch clinical trials.
0115
Roychoudhuri Lab @roychoudhurilab.bsky.social · 04/09/2026
Thank you Bob - I am most familiar with your work and would be interesting to map global effects of ROS on phosphatase regulation after TCR signaling in T cells perhaps using cysteine proteomics.. You come up in conversations with Klaus Okkenhaug quite often incidentally!
120
Roychoudhuri Lab @roychoudhurilab.bsky.social · 04/09/2026
Thank you Noe!
020
Reposted by Roychoudhuri Lab
ImmuNoah's Ark (Noe Rodriguez) @immunoah.bsky.social · 04/09/2026
Beautiful work by @roychoudhurilab.bsky.social!
021
Roychoudhuri Lab @roychoudhurilab.bsky.social · 04/09/2026
Amazing! Powerful progress in the right directions can happen!
010
Roychoudhuri Lab @roychoudhurilab.bsky.social · 04/09/2026
Many thanks Ivan!
020
Reposted by Roychoudhuri Lab
Waggoner Lab @labwaggoner.bsky.social · 04/09/2026
An antioxidant released by tumors dampens T cell immunity @science.org @roychoudhurilab.bsky.social @universitypress.cambridge.org @ohsuknight.bsky.social www.science.org/doi/10.1126/... www.science.org/doi/10.1126/...
031
Roychoudhuri Lab @roychoudhurilab.bsky.social · 04/09/2026
Delighted to share new work published in @science.org entitled 'Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species,' led by @xanwesolowski.bsky.social in the lab science.org/eprint/YQNFA...
33310
Roychoudhuri Lab @roychoudhurilab.bsky.social · 16/08/2026
It's now been 5 years since we replaced our relatively new gas boiler for a #heatpump in our home - and we haven't looked back! Comfortably warm in winter, no damp on walls anymore, ~reduced cost, massive reduction in CO2 emissions. 2-day install! Notes here: sites.google.com/view/becomin...
sites.google.com
Home
We are a family of four living in a 1930's semi-detached house in Cambridge, UK. Here are the steps we've taken to reduce our ecological footprint.
031
Reposted by Roychoudhuri Lab
The Lister Institute of Preventive Medicine @thelisterinstitute.bsky.social · 02/03/2026
Right BACH2 at you @roychoudhurilab.bsky.social 😆 Fantastic to see research on BACH2 from former #ListerFellow Rahul Roychoudhuri and colleagues included in Nature News and Views. Read the paper on fine-tuning BACH2 dosage to enhance antitumor T cell therapy⤵️ www.nature.com/articles/s41...
nature.com
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy - Nature Immunology
One of three back-to-back papers to show dosage of BACH2 can modulate T cell differentiation and function and how we might apply this to enhance chimeric antigen receptor T cell therapies for cancer.
032
Reposted by Roychoudhuri Lab
Payal Yokota @payalyokota.bsky.social · 01/05/2026
A compelling shift toward tissue-centric immunity: lymphoid niches don’t just initiate responses—they time and constrain them. Brilliant now work from Lukas Altenberger shows that timing of initiating and terminating immune response are equally important. www.science.org/doi/10.1126/...
science.org
Lymphoid tissue chemokines limit priming duration to preserve CD8+ T cell functionality
The generation of effector CD8+ T cells (TEFF) requires activation of naïve CCR7+ T cells (TN) by dendritic cells (DCs) in lymphoid tissue. How TN-DC interaction duration and signal integration are co...
072
Roychoudhuri Lab @roychoudhurilab.bsky.social · 01/05/2026
Incredible paper from Max Krummel's lab showing macrophages can sample cellular content from living cells for presentation to T cells pubmed.ncbi.nlm.nih.gov/42056510/
082
Roychoudhuri Lab @roychoudhurilab.bsky.social · 26/02/2026
Great News&Views piece covering the three papers on BACH2 dosing recently published in @natimmunol.nature.com Love the title: BACH2 the future! www.nature.com/articles/s41...
072
Roychoudhuri Lab @roychoudhurilab.bsky.social · 26/02/2026
Great News & Views piece on the three BACH2 dosing papers recently published in @natimmunol.nature.com Love the title.. BACH2 the future! www.nature.com/articles/s41...
010
Roychoudhuri Lab @roychoudhurilab.bsky.social · 05/02/2026
Immunoinformatics is revolutionising our understanding of cancer immunology and immunotherapy responses. If anyone is interested in joining our lab through this fellowship, I'd be very keen to support an application - do get in touch! www.cancerresearch.org/immuno-infor...
cancerresearch.org
Immuno-Informatics Postdoctoral Fellowship | Cancer Research Institute
The CRI Immuno-Informatics Postdoctoral Fellowship Program supports young scientists at institutions who wish to receive dual training in immunology.
061
Roychoudhuri Lab @roychoudhurilab.bsky.social · 04/02/2026
A great piece in ACIR discussing the there papers on #BACH2 dosing for T cell therapy of cancer recently out in @NatImmunol bit.ly/3atHQyV
052
Roychoudhuri Lab @roychoudhurilab.bsky.social · 03/02/2026
031
Roychoudhuri Lab @roychoudhurilab.bsky.social · 03/02/2026
Absolutely remarkable: striking effects of infusion time-of-day on immunochemotherapy efficacy in nonsmall cell lung cancer in a randomized phase 3 trial www.nature.com/articles/s41...
nature.com
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial - Nature Medicine
In this randomized phase 3 trial, patients with treatment-naive stage III–IV nonsmall cell lung cancer who received sintilimab or pembrolizumab in combination with chemotherapy early in the day (befor...
183
Reposted by Roychoudhuri Lab
Jaehyuk Choi @jaehyukchoimd.bsky.social · 20/09/2025
We have an active search for tenure-track faculty interested in #ImmuneEngineering #ProteinEngineering #GenomeEngineering & #CancerImmunology. Join the newly formed Center for Cellular Therapies and Cancer Immunology #CCTCI. Learn more at apply.interfolio.com/173562. #facultyjobs
apply.interfolio.com
Apply - Interfolio {{$ctrl.$state.data.pageTitle}} - Apply - Interfolio
063
Reposted by Roychoudhuri Lab
Ian Parish @ianparish.bsky.social · 17/01/2026
Great to see this out, it was fun to work with Roychoudhuri lab on this really nice story. A good illustration that too much "stemness" in T cells can be a bad thing.
081
Reposted by Roychoudhuri Lab
Waggoner Lab @labwaggoner.bsky.social · 19/01/2026
Unraveling CD8 lineage decisions reveals that functionally distinct CD8+ T cells are selected by different MHC-I thymic peptides @natimmunol.nature.com www.nature.com/articles/s41...
0126
Reposted by Roychoudhuri Lab
Roychoudhuri Lab @roychoudhurilab.bsky.social · 16/01/2026
The paper is part of three parallel submissions from the labs of Nathan Singh & Tuoqi Wu arriving at similar conclusions - that the dosage of BACH2 and the timing of its induction are key to enhancing #celltherapy for cancer. @Cambridge_Uni @CRUKCambridge
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy
063
Reposted by Roychoudhuri Lab
Pestilence @pestilence4all.bsky.social · 17/01/2026
New study suggests that metastatic cancer cells may evade the immune system by stealing mitochondria from immune cells and setting up a ‘shield’ that protects them from being killed by immune cells. Wiley little bastards. #Science 🧪
nature.com
Cancer might evade immune defences by stealing mitochondria
Hijacking the energy-producing organelles from immune cells seems to help tumours in mice to infiltrate lymph nodes.
992735758
Reposted by Roychoudhuri Lab
UT MD Anderson Cancer Center @mdanderson.bsky.social · 17/01/2026
"It’s exciting to think that the new therapy that helped me might be able to save other people, too," says JC Cox. He was only the eighth person at MD Anderson to be treated with CAR NK cells. Read his story: spr.ly/63326C03Jo #OncSky #EndCancer
spr.ly
CAR NK cell therapy clinical trial puts follicular lymphoma survivor into remission  
Non-Hodgkin lymphoma survivor JC Cox turned to MD Anderson when local treatment failed to keep the cancer at bay. Here, a single dose of a novel cell therapy administered through a clinical trial has put — and kept — him in remission.
062
Reposted by Roychoudhuri Lab
Jon Cooper @joncooper-us.bsky.social · 16/01/2026
Terribly uncanny how relevant this is to today.
516115405241
Reposted by Roychoudhuri Lab
Nature Medicine @natmed.nature.com · 17/01/2026
In a phase 2 trial, low-dose interleukin-2 boosted regulatory T cells and reduced arterial inflammation in acute coronary syndrome patients compared to placebo. www.nature.com/articles/s41591-025-…
066
Reposted by Roychoudhuri Lab
George Conway ⚖️🇺🇸 @gtconway.bsky.social · 17/01/2026
742123275041
Roychoudhuri Lab @roychoudhurilab.bsky.social · 17/01/2026
Super cool..
021
Roychoudhuri Lab @roychoudhurilab.bsky.social · 17/01/2026
Thanks Jaehyuk.. hope all is well
000
Roychoudhuri Lab @roychoudhurilab.bsky.social · 17/01/2026
Wonderful to collaborate with you on this Ian and enormous thanks to Christian, Shienny and Nicole for the heavy lifting!
110
Reposted by Roychoudhuri Lab
Waggoner Lab @labwaggoner.bsky.social · 17/01/2026
BACH2 dosage balances stemness & effector functions of antitumor T & CAR-T @natimmunol.nature.com @roychoudhurilab.bsky.social @ianparish.bsky.social @washumedicine.bsky.social @utswim.bsky.social www.nature.com/articles/s41... www.nature.com/articles/s41... www.nature.com/articles/s41...
152
Reposted by Roychoudhuri Lab
Roychoudhuri Lab @roychoudhurilab.bsky.social · 16/01/2026
Thrilled to share our latest work: Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy - now online in Nature Immunology. Led by Alberto Conti, Alex Evans and Teresa von Linde in the lab. www.nature.com/articles/s41...
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy
2247
Roychoudhuri Lab @roychoudhurilab.bsky.social · 16/01/2026
Thrilled to share our latest work: Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy - now online in Nature Immunology. Led by Alberto Conti, Alex Evans and Teresa von Linde in the lab. www.nature.com/articles/s41...
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy
2247
Roychoudhuri Lab @roychoudhurilab.bsky.social · 16/12/2025
Fantastic overview of mechanisms by which low-dose #Aspirin exerts prevents #metastasis in cancer www.nejm.org/doi/full/10....
nejm.org
Understanding How Aspirin Prevents Metastasis | NEJM
A new study shows that aspirin enhances antimetastatic immunity by decreasing platelet activation, thereby releasing T cells from suppression by thromboxane A2.
040
Reposted by Roychoudhuri Lab
Cancer Research UK Cambridge Centre @crukcamcentre.bsky.social · 10/12/2025
📢 Don’t miss the last Cancer Biology and Medicine talk of 2025 tomorrow! Cancer immunology and immunotherapy Prof Rahul Roychoudhuri @campathology.bsky.social 📅 Thurs 11 December, 9:30-10:30 📍Theo Chalmers lecture theatre, School of Clinical Medicine All welcome! @cambridge-scm.bsky.social
002
Reposted by Roychoudhuri Lab
St Catharine's College @stcatharines.bsky.social · 01/12/2025
Catz researchers teach old drugs new tricks: @roychoudhurilab.bsky.social (2020) on how aspirin could prevent some cancers from spreading: www.caths.cam.ac.uk/... PhD work by Felicity Crawshay-Williams led to the identification of new combinations of existing antibiotics: www.caths.cam.ac.uk/...
011
Roychoudhuri Lab @roychoudhurilab.bsky.social · 10/11/2025
We're hiring! We are looking for a Research Assistant with protein biochemistry skills to develop novel protein-based immunotherapeutics targeting Treg cells in cancer. You'll join @roychoudhurilab.bsky.social @campathology.bsky.social @crukcamcentre.bsky.social Apply: jobs.cam.ac.uk/job/53219/
081
Reposted by Roychoudhuri Lab
Carlos Ribeiro @ribeirocarlitos.bsky.social · 08/10/2025
Interesting how companies and the financial world is racing to spend mindboggling amounts of money to build the infrastructure to train computers. But we are leaving the infrastructure to train and educate humans crumbling. The question is who will train who?
media.tenor.com
a man in a suit is holding a jacket and a cigarette .
ALT: a man in a suit is holding a jacket and a cigarette .
37116
Roychoudhuri Lab @roychoudhurilab.bsky.social · 09/10/2025
A more consistently warm home, no damp on the walls in winter and much cheaper heating
010
Roychoudhuri Lab @roychoudhurilab.bsky.social · 06/10/2025
Wonderful to see the seminal discoveries of Shimon Sakaguchi, Mary E. Brunkow & Fred Ramsdell recognised with the Nobel Prize. From Sakaguchi’s discovery of Treg cells to the identification of Foxp3, their research opened a new chapter in immunology, viewed from the prism of dominant tolerance.
0102
Reposted by Roychoudhuri Lab
Seth Thomas Scanlon @immunoeditor.bsky.social · 19/09/2025
Now in #Science #Immunology: @griffithslab.bsky.social report that when #CD8 #TCells encounter their targets, #nucleus localizes to the #ImmuneSynapse (IS) & facilitates delivery of newly synthesized cytokines to the IS. They find nuclear polarization represents key step in #CTL -mediated killing!
science.org
Nuclear polarization to the immune synapse facilitates an early transcriptional burst
Cytotoxic T lymphocyte target recognition triggers rapid nuclear polarization to the immune synapse and an early transcriptional burst of cytokines.
0265
Roychoudhuri Lab @roychoudhurilab.bsky.social · 19/09/2025
The new #ALASCCA RCT shows that low-dose aspirin prevents metastatic recurrence by ~50% in patients with PI3K altered colorectal cancer #aspirin #metastasis #prevention
040
Roychoudhuri Lab @roychoudhurilab.bsky.social · 12/09/2025
A fantastic 2 days in Lille thinking T cell therapy at CAR T Day - the 9th international symposium on CAR T cells cartday.org. Thanks to Suman Mitra for the invitation to share our new data
cartday.org
CAR T Day
International Symposium on CAR T Cells
030
Roychoudhuri Lab @roychoudhurilab.bsky.social · 14/08/2025
Cool to see so many #heatpumps being installed this year. We’ve had our heatpump at home now for 3 years and it’s been saving us money while providing more comfortable heating and reducing our estimated CO2e by 75-80%.
252